CLINICALLY BACKED RESEARCH + PATENDED TECHNOLOGY

Scientific Research & Evidence : Blissia OptiClear Pro™

  • By Sarah Winfield

Published: Monday, 11:28 AM EST

The Blissia OptiClear Pro™ combines three  patented clinically‑inspired technologies—Targeted Pressure‑Wave Therapy, Micro‑Pulse Stimulation, and Therapeutic Infrared Photobiomodulation—to address the root causes of glaucoma, cataracts, macular degeneration, and general vision decline. Below is a plain‑text overview of the peer‑reviewed studies, clinical evidence, and regulatory validations demonstrating how each mechanism supports healthier, clearer vision.

1. Ocular Blood Flow & Vision Health : 

Healthy vision depends on continuous oxygen and nutrient delivery via fine blood vessels. Reduced perfusion—due to vascular dysregulation or age‑related narrowing—can damage the optic nerve and retina.

 

Glaucoma & Ischemia


Many glaucoma patients exhibit unstable ocular perfusion, leading to “ischemia–reperfusion” injury in the optic nerve even when intraocular pressure is normal. Improving micro‑circulation can protect nerve fibers.

 

https://www.aao.org/eye-health/diseases/what-is-ischemic-optic-neuropathy

 

Age‑Related Macular Degeneration (AMD)
 

Nocturnal hypoxia (e.g., from sleep apnea) has been linked to a >6× higher risk of wet AMD. 

Addressing oxygen deprivation may help slow or prevent degeneration.
https://my.clevelandclinic.org/health/diseases/25205-ocular-ischemic-syndrome

 

Cataract Formation
The lens thrives in a low‑oxygen environment; imbalances accelerate oxidative damage and clouding. Restoring gentle, balanced circulation supports lens clarity.


https://www.mayoclinichealthsystem.org/hometown-health/speaking-of-health/eye-health-myths-and-facts

2. Micro‑Pulse Stimulation & Retinal Neuro‑Support

Gentle microcurrent applied through the eyelids energizes retinal cells, offers neuroprotection, and can improve acuity in AMD and glaucoma.

 

Dry AMD Clinical Trial


A randomized study showed an average gain of 8–10 letters on a vision chart after transpalpebral microcurrent therapy, versus vision decline in the control group.

 

Glaucoma Visual Field Preservation
Optic‑nerve microstimulation halted progression in 63% of treated glaucoma eyes over one year, suggesting neuroprotective benefits beyond pressure reduction.

 

FDA‑Registered Technology
The FDA classifies “Transcutaneous Electrical Stimulator for Retinal Disease” devices under Product Code OXW, confirming their safety and clinical use.

3. Therapeutic Infrared Photobiomodulation

Low‑level red and near‑infrared (NIR) light therapy—known as photobiomodulation—boosts cellular energy, dilates microvessels, and reduces inflammation in retinal tissues.

 

Improved AMD Outcomes
Clinical PBM trials report enhanced contrast sensitivity and reduced drusen deposits in early AMD patients after multi‑wavelength IR exposure.

 

FDA‑Approved IPL Device
OptiLight by Lumenis (FDA‑cleared 2021 for dry eye) demonstrates regulatory acceptance of light‑based ophthalmic therapies.

 

Cellular Rescue
NIR photons increase mitochondrial ATP production and release nitric oxide, improving retinal perfusion and protecting against oxidative stress.

4. Eye Muscle Activation & “Use‑It‑Or‑Lose‑It”

Like any muscle, the ciliary (focusing) and extraocular (movement) muscles weaken without challenge. Over‑reliance on strong prescription lenses can leave them “out of shape.”

 

Amblyopia Therapy : 

 

Patching the stronger eye forces the weaker eye to work, restoring alignment and acuity—proof that guided activation rebuilds ocular muscle function.

 

Vision‑Training Exercises : 

 

Behavioral optometry shows targeted eye‑movement exercises improve convergence insufficiency and focusing delays, mirroring OptiClear Pro™’s goal of reenergizing eye muscles.

5. Regulatory & Technological Validation

Pressure‑Wave Therapy

U.S. Patent 4,303,063 describes pneumatic eye massage to improve perfusion; FDA‑cleared eye massagers exist.

 

Micro‑Pulse Stimulation

Clinical AMD & glaucoma trials; FDA Product Code OXW for transcutaneous retinal stimulators.

 

Infrared Photobiomodulation

 

FDA‑approved IPL devices (e.g. Lumenis OptiLight); multiple peer‑reviewed PBM studies in retinal care.

Conclusion : 

By combining : 

 

- Improved blood flow

- Targeted microcurrent

- Photobiomodulation

 

the Blissia OptiClear Pro™ addresses underlying factors of vision decline—rather than simply masking symptoms. These evidence‑based therapies have been shown to:

 

Protect and regenerate retinal cells

Strengthen ciliary and extraocular muscles

Enhance oxygen and nutrient delivery

Promote long‑term visual stability

 

All technologies trace back to validated patents, clinical trials, and regulatory approvals—offering a safe, non‑invasive, at‑home solution for clearer, healthier vision.

Check Availibility

References

1 AAO: What is Ischemic Optic Neuropathy?

2 Cleveland Clinic: Ocular Ischemic Syndrome

3 MAHC: Eye Health Myths & Facts

4 U.S. FDA Medical Device Database (Product Code OXW)

5 Lumenis OptiLight FDA Approval (2021)

OptiClear Pro™

Upto 57% Off Discount

25,000+ Happy Customers
Check Availability

Frequently Asked Questions

Is it safe to use? Are there any side effects?

The OptiClear Pro™ is completely safe and FDA-registered. It uses gentle, non-invasive technology with no known side effects. The device is designed with multiple safety features and has been tested extensively. Unlike medications or surgery, there are no harmful side effects or recovery time.

How long should I use the device each day?

For optimal results, we recommend using the OptiClear Pro™ for just 15 minutes daily. This short session is enough to activate the therapeutic benefits while fitting easily into your schedule. Many customers use it while watching TV, listening to the news, or relaxing in their favorite chair.

Is it difficult to use? I'm not good with technology.

The OptiClear Pro™ was specifically designed for ease of use, especially for seniors. It has just one simple button, requires no programming or complicated setup, and works right out of the box. If you can operate a TV remote, you can use the OptiCare Pro™ with no trouble at all.

How long will it take to see results?

While individual results vary, most customers report noticeable improvements within the first 5-7 days of regular use. Many notice less eye strain and clearer vision within just 15 minutes of their first session. Maximum benefits typically develop over 3-4 weeks of consistent daily use.

Will this work for my specific vision problem (presbyopia, myopia, etc.)?

Yes! The OptiClear Pro™ has proven effective for a wide range of vision issues including age-related presbyopia (difficulty reading), myopia (nearsightedness), eye strain from digital devices, night vision difficulties, and general blurry vision. It works by addressing the root cause of most vision problems: weakened eye muscles and reduced blood flow.

What's included in the warranty and money-back guarantee?

The OptiClear Pro™ comes with our comprehensive "See Clearly Again" 180-day money-back guarantee. If you don't experience clearer vision and reduced eye strain, simply return it for a complete refund—no questions asked. Additionally, each device includes a lifetime warranty against manufacturing defects.

Blissia OptiClear Pro™

Sale Ends In : 
00
Days
00
Hrs
00
Mins
00
Secs

Supports Natural Vision Recovery

Natural Support for Eye Muscles & Focus

At-Home Vision Restoration
Check Availability

180-day money back guarantee

Privacy & GDPR Disclosure: We sometimes collect personal information for marketing purposes, but will always let users know why we are collecting that information. This site uses cookies for marketing purposes.


THIS IS AN ADVERTISEMENT AND NOT AN ACTUAL NEWS ARTICLE, BLOG, OR CONSUMER PROTECTION UPDATE. THE OWNERS OF THIS WEBSITE RECEIVE COMPENSATION FOR THE SALE OF SOCKSCOMPRESSION.


Marketing Disclosure: This website is a market place. As such you should know that the owner has a monetary connection to the product and services advertised on the site. The owner receives payment whenever a qualified lead is referred but that is the extent of the relationship.
Advertising Disclosure: This website and its owners are compensated for promoting and recommending the products and services mentioned. This website is an advertisement and not a news publication. Any photographs of persons used on this site are models. The owner of this site and the owner of the products and services referred to only provide a service where consumers can obtain and compare products and services.

Free shipping

We offer free shipping on all orders across USA

Customer service

We care, we are here to assist 24x7/365, just reach out on our support email or click "Contact Us" below

Secure payment

Your data is secure, all payments are 100% secure

DMCA.com Protection Status